Phase II trial of chemoradiotherapy with S-1 plus cisplatin for unresectable locally advanced head and neck cancer (JCOG0706)

We conducted a phase II study to evaluate the efficacy and safety of chemoradiotherapy concurrent with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck. Chemotherapy consisted of S-1 twice daily on days 1–14 at 60 mg/m(2)/day and cisplati...

Descripción completa

Detalles Bibliográficos
Autores principales: Tahara, Makoto, Kiyota, Naomi, Mizusawa, Junki, Nakamura, Kenichi, Hayashi, Ryuichi, Akimoto, Tetsuo, Hasegawa, Yasuhisa, Iwae, Shigemichi, Monden, Nobuya, Matsuura, Kazuto, Fujii, Hirofumi, Onozawa, Yusuke, Homma, Akira, Kubota, Akira, Fukuda, Haruhiko, Fujii, Masato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471783/
https://www.ncbi.nlm.nih.gov/pubmed/25781202
http://dx.doi.org/10.1111/cas.12657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471783/
https://www.ncbi.nlm.nih.gov/pubmed/25781202
http://dx.doi.org/10.1111/cas.12657

Ejemplares similares